Development of Novel Isatin-Tethered Quinolines as Anti-Tubercular Agents against Multi and Extensively Drug-Resistant Mycobacterium tuberculosis
暂无分享,去创建一个
Mohamed A. Abdelrahman | T. Al-Warhi | Wagdy M. Eldehna | Mohamed A. Said | M. Abdel-Aziz | Hadia Almahli | Taghreed A. Majrashi
[1] Wagdy M. Eldehna,et al. Design and synthesis of thiazolidine-2,4-diones hybrids with 1,2-dihydroquinolones and 2-oxindoles as potential VEGFR-2 inhibitors: in-vitro anticancer evaluation and in-silico studies , 2022, Journal of enzyme inhibition and medicinal chemistry.
[2] Vipan Kumar,et al. A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs) , 2022, Pharmaceuticals.
[3] Visweswara Rao Pasupuleti,et al. Therapeutic Outcomes of Isatin and Its Derivatives against Multiple Diseases: Recent Developments in Drug Discovery , 2022, Pharmaceuticals.
[4] Nahla A. Abdelshafi,et al. Development of Potent Nanosized Isatin-isonicotinohydrazide Hybrid for Management of Mycobacterium Tuberculosis. , 2021, International journal of pharmaceutics.
[5] Luoting Yu,et al. Discovery of quinolone derivatives as antimycobacterial agents , 2021, RSC advances.
[6] Heba S. A. Elzahabi,et al. Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation , 2021, Journal of enzyme inhibition and medicinal chemistry.
[7] H. Abdel‐Aziz,et al. Development of novel isatin–nicotinohydrazide hybrids with potent activity against susceptible/resistant Mycobacterium tuberculosis and bronchitis causing–bacteria , 2021, Journal of enzyme inhibition and medicinal chemistry.
[8] A. Burke,et al. The application of isatin-based multicomponent-reactions in the quest for new bioactive and druglike molecules. , 2020, European journal of medicinal chemistry.
[9] S. Verma,et al. Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review. , 2020, European journal of medicinal chemistry.
[10] A. Villela,et al. Anti-tubercular profile of new selenium-menadione conjugates against Mycobacterium tuberculosis H37Rv (ATCC 27294) strain and multidrug-resistant clinical isolates , 2020, European Journal of Medicinal Chemistry.
[11] B. Gicquel,et al. Phenanthrolinic analogs of quinolones show antibacterial activity against M. tuberculosis. , 2020, European journal of medicinal chemistry.
[12] A. Turjanski,et al. New one-pot synthesis of anti-tuberculosis compounds inspired on isoniazid. , 2020, European journal of medicinal chemistry.
[13] K. N. Venugopala,et al. Cytotoxicity and Antimycobacterial Properties of Pyrrolo[1,2-a]quinoline Derivatives: Molecular Target Identification and Molecular Docking Studies , 2020, Antibiotics.
[14] Jingtao Gao,et al. Interpretation on key points of World Health Organization global tuberculosis report 2019 , 2020 .
[15] J. Guzman,et al. Antimicrobial Activity of Quinoline-Based Hydroxyimidazolium Hybrids , 2019, Antibiotics.
[16] Varun,et al. Isatin and its derivatives: a survey of recent syntheses, reactions, and applications. , 2019, MedChemComm.
[17] S. Bari,et al. ISATIN: New Hope Against Convulsion. , 2018, Central nervous system agents in medicinal chemistry.
[18] Gang‐Qiang Wang,et al. Isatin Derivatives with Potential Antitubercular Activities , 2018 .
[19] Riham F. George,et al. Synthesis and biological evaluation of 2-aminothiazole-thiazolidinone conjugates as potential antitubercular agents. , 2018, Future medicinal chemistry.
[20] G. Piazza,et al. Synthesis and biological evaluation of certain hydrazonoindolin-2-one derivatives as new potent anti-proliferative agents , 2018, Journal of enzyme inhibition and medicinal chemistry.
[21] H. Abdel‐Aziz,et al. Novel 6-Phenylnicotinohydrazide Derivatives: Design, Synthesis and Biological Evaluation as a Novel Class of Antitubercular and Antimicrobial Agents. , 2017, Biological & pharmaceutical bulletin.
[22] Mohamed A. Abdelrahman,et al. Design, synthesis and 2D QSAR study of novel pyridine and quinolone hydrazone derivatives as potential antimicrobial and antitubercular agents. , 2017, European journal of medicinal chemistry.
[23] Zhi Xu,et al. Isatin hybrids and their anti-tuberculosis activity , 2017 .
[24] Jana Korduláková,et al. Pyrrolidinone and pyrrolidine derivatives: Evaluation as inhibitors of InhA and Mycobacterium tuberculosis. , 2016, European journal of medicinal chemistry.
[25] Hazem A. Ghabbour,et al. Synthesis and Cytotoxic Activity of Biphenylurea Derivatives Containing Indolin-2-one Moieties , 2016, Molecules.
[26] Mohamed Fares,et al. Synthesis, in Vitro and in Silico Studies of Some Novel 5-Nitrofuran-2-yl Hydrazones as Antimicrobial and Antitubercular Agents. , 2015, Biological & pharmaceutical bulletin.
[27] M. Gupta,et al. Quinoline and quinolones: promising scaffolds for future antimycobacterial agents , 2015, Journal of enzyme inhibition and medicinal chemistry.
[28] Mohamed Fares,et al. Design, Synthesis and Antitubercular Activity of Certain Nicotinic Acid Hydrazides , 2015, Molecules.
[29] Khalid A. Al-Rashood,et al. Synthesis, Biological Evaluation and 2D-QSAR Study of Halophenyl Bis-Hydrazones as Antimicrobial and Antitubercular Agents , 2015, International journal of molecular sciences.
[30] Rangappa S. Keri,et al. Quinoline: a promising antitubercular target. , 2014, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
[31] H. Fun,et al. Synthesis, Crystal Structure, and Biological Activity of cis/trans Amide Rotomers of (Z)-N -(2-Oxoindolin-3-ylidene)formohydrazide , 2014 .
[32] A. Kumar,et al. Synthesis of substituted-4-oxo-1, 4-dihydro-3-[1-oxo-2-hydrazino-3-{p-toluenesulfon}]quinoline Derivatives and their Biological Activity Against Bacterial Infections , 2013 .
[33] I. Briguglio,et al. SAR and Anti-Mycobacterial Activity of Quinolones and Triazoloquinolones: An Update , 2012 .
[34] A. V. Adhikari,et al. Design, synthesis and docking studies of new quinoline-3-carbohydrazide derivatives as antitubercular agents. , 2011, European journal of medicinal chemistry.
[35] Hemantkumar S. Deokar,et al. Novel quinoline and naphthalene derivatives as potent antimycobacterial agents. , 2010, European journal of medicinal chemistry.
[36] A. V. Adhikari,et al. Design and synthesis of some new quinoline-3-carbohydrazone derivatives as potential antimycobacterial agents. , 2010, Bioorganic & medicinal chemistry letters.
[37] M. Shahlaei,et al. QSAR study of some 5-methyl/trifluoromethoxy- 1H-indole-2,3-dione-3-thiosemicarbazone derivatives as anti-tubercular agents , 2009, Research in pharmaceutical sciences.
[38] N. Karalı,et al. Synthesis and antituberculosis activity of 5-methyl/trifluoromethoxy-1H-indole-2,3-dione 3-thiosemicarbazone derivatives. , 2008, Bioorganic & medicinal chemistry.
[39] A. Dimoglo,et al. Synthesis and structure-antituberculosis activity relationship of 1H-indole-2,3-dione derivatives. , 2007, Bioorganic & medicinal chemistry.
[40] J. Jampílek,et al. A new modification of anti-tubercular active molecules. , 2007, Bioorganic & medicinal chemistry.
[41] A. Malde,et al. Synthesis, anti-tuberculosis activity, and 3D-QSAR study of ring-substituted-2/4-quinolinecarbaldehyde derivatives. , 2006, Bioorganic & medicinal chemistry.
[42] A. Kozikowski,et al. Design, Synthesis, and SAR Studies of Mefloquine‐Based Ligands as Potential Antituberculosis Agents , 2006, ChemMedChem.
[43] Robert H. Gilman,et al. Rapid, Low-Technology MIC Determination with Clinical Mycobacterium tuberculosis Isolates by Using the Microplate Alamar Blue Assay , 1998, Journal of Clinical Microbiology.
[44] L. Collins,et al. Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium , 1997, Antimicrobial agents and chemotherapy.
[45] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.